Neil Mark Sussman is a Allentown, Pennsylvania based neurologist who is specialized in Neurology. Active license number of Neil Mark Sussman is MD015758E for Neurology in Pennsylvania. His current practice location is 4051 Primrose Dr, Allentown. Patients can reach him at 610-395-7475. Neil Mark Sussman is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1679724728. Neil Mark Sussman specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Neil Mark Sussman speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1679724728
NPI Enumeration Date:
07 Oct, 2008
NPI Last Update On:
07 Oct, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Neil Mark Sussman are as mentioned below.
License Number
Specialization
State
Status
MD015758E
Neurology
Pennsylvania
Primary
MD015758-E
Neurology
Pennsylvania
Secondary
MD015758E
Psychiatry & Neurology
Pennsylvania
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Neil Mark Sussman 35 Elm Pl, Milltown, New Jersey
Zip:
08850-1145
Phone Number:
732-342-9764
Patients can reach Neil Mark Sussman at 4051 Primrose Dr, Allentown, Pennsylvania or can call to book an appointment on 610-395-7475.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.